Loading Events
Find Webinars

Event Views Navigation

June 2020

“Drug Allergies & Cross-Sensitivities”

https://share.vidyard.com/watch/SKVsRf4Em4s579yvvkhKZh? Download a copy of this content. HealthTrust presents..."Drug Allergies & Cross-Sensitivities" Healthcare professionals are aware of drug allergies and the cross-reactivities of drug classes, but there remains a gap in knowledge regarding their rate and prevalence. It is not a simple decision on choosing alternative therapies when a patient presents with a common allergy. Alternatives exist to be used if a common drug allergy is present, but decisions are made at times without the data and research at hand.…

Find out more »

May 2020

“Hot Topics in Geriatric Medicine: Vaccination in Older Adults”

https://share.vidyard.com/watch/DS9DaY5QqLcxpjKNDNpW7k? Download a copy of this content. HealthTrust presents..."Hot topics in Geriatric Medicine: Vaccination in Older Adults" Recently there have been many changes to vaccination guidelines and/or availability for older adults. In November 2019, the CDC updated the recommendation for PPSV23 among adults ≥65 to include a component of shared decision-making. Additionally, the CDC has provided clinical guidance for vaccination against shingles during the evolving shortages of Shingrix. Older adults are also at a higher risk of developing serious complications…

Find out more »

“TenectePLACE in Acute Stroke Management”

https://share.vidyard.com/watch/w4inqbHpQuKNPKkLRTjQXg? Download a copy of this content. HealthTrust presents..."TenectePLACE in Acute Stroke Management" Acute ischemic stroke (AIS) is the leading cause of lifelong disability affecting about 700,000 patients annually. Goals of AIS treatment include minimizing neurologic injury by reducing clot burden and restoring adequate blood flow to the brain to reduce the likelihood of lifelong disability. Current standard of care includes treatment with intravenous fibrinolytic therapy and/or mechanical thrombectomy. Currently, recombinant tissue plasminogen activator (tPA) is the FDA approved treatment…

Find out more »

“Management of Inpatient Anticoagulation Therapy”

  https://share.vidyard.com/watch/5bzYZjVj1bq8i2wYgXw6pY? Download a copy of this content HealthTrust presents..."Management of Inpatient Anticoagulation Therapy" DOAC therapy has been in use for over a decade. However, there are still gaps in knowledge when it comes to proper management of therapy. Dosing in renal dysfunction, obesity, periprocedural management, as well as transitions between different therapies are all questions that clinicians must be able to answer. The presenter will review the management of inpatient anticoagulation therapy and characterize important pharmacokinetics and pharmacodynamics, including…

Find out more »

April 2020

“Biostatistics & Clinical Application Review”

  https://share.vidyard.com/watch/xTF2zRjWNgrS8teAbUhtsW? Download a copy of this content. Healthtrust presents..."Biostatistics and Clinical Application Review" Pharmacists are taught biostatistics and how to apply them to clinical practice while in school, but do not always retain this information. Trials comparing drugs currently used in practice or testing the efficacy and safety of new medications are continuously being published. Pharmacists must be able to correctly make their own conclusions from the data provided instead of relying on that written by the authors to…

Find out more »

“Trauma to the Brain? Osmotics are the Game: An Update on Traumatic Brain Injury and Hyperosmolar Therapy”

https://share.vidyard.com/watch/NygZh6ugKjQNhmZ21P5qjo? Download a copy of this content. Healthtrust presents..."Trauma to the Brain? Osmotics are the Game: An Update on Traumatic Brain Injury and Hyperosmolar Therapy". Severe brain injury due to trauma is associated with high mortality. Approximately 50,000 people die from a traumatic brain injury (TBI) each year in the United States. Mortality from TBI is usually due to several factors including, elevated intracranial pressure (ICP), severe intracranial hemorrhage and coagulopathy, impaired oxygenation and ventilation, and seizures. Management of TBI…

Find out more »

“Multiple Sclerosis”

https://share.vidyard.com/watch/ZR6K6z5NP7mpMH7SFPXw2W Download a copy of this content. HealthTrust presents..."Multiple Sclerosis" Multiple sclerosis is a lesser known and complex disease state. There remains a gap in knowledge of the prevalence, etiology, phenotypes and treatment options of multiple sclerosis. Individualizing treatment regimens remains a particular challenge to encourage compliance while providing sufficient treatment to prevent disease progression for multiple sclerosis. Additionally, there is little data to directly compare and contrast disease modifying therapies. In this session, the presenter will examine multiple sclerosiss’…

Find out more »

“Drug Information: Searching Medical Literature”

https://share.vidyard.com/watch/QSYhwPAQRXR4p2ubhH2Kdx? Download a copy of this content. HealthTrust presents..."Drug Information: Searching Medical Literature" Despite being an essential part of a healthcare professional, many pharmacists and nurses may not know where to start when asked to search medical literature in response to a question from another healthcare provider or patient. As a result, pharmacists and nurses are limited in their ability to quickly but thoroughly respond to inquiries which may ultimately lead to a delay in patient care. Healthcare professionals must stay…

Find out more »

March 2020

Novel Coronavirus (COVID-19) Update

HealthTrust hosted a live webinar event on March 17: "Novel Coronavirus (COVID-19) Update" Links to important resources from the CDC, WHO and more... On the last day of 2019, a pneumonia of unknown cause was detected in Wuhan, China, and first reported to the World Health Organization (WHO). The virus has continued to spread and the outbreak declared a “public health emergency of international concern” on Jan. 30, 2020. The WHO has since announced a name for the new coronavirus…

Find out more »

“Tip of the Iceberg: Alterations of PK/PD in Patients Undergoing Targeted Temperature Management”

https://share.vidyard.com/watch/6DoPse6hqmFpACRQw8Jk6Q? Download a copy of this content. HealthTrust presents..."Tip of the Iceberg: Alterations of PK/PD in Patients Undergoing Targeted Temperature Management" Targeted temperature management (TTM), or therapeutic hypothermia (TH), is utilized in cardiac arrest patients following ROSC to preserve neurologic function and improve long term outcomes. The induction, maintenance and rewarming experienced by the patient during TTM causes acute physiological changes, namely shivering, that are managed by a variety of pharmacotherapies.   Additionally, lower temperatures impact the pharmacokinetics (PK) of many…

Find out more »
+ Export Events